Incentive · Pharma & Life Sciences
Compliance-aware luxury — for the industry where the rules matter most.
Programs designed within PhRMA, EFPIA and MHRA frameworks. Pharma sales incentives, KOL meetings, biotech partner programs, medical device sales rewards. We work with your compliance team from day one.
Enquire about a 2026 programWhy compliance is the design driver, not an afterthought
The pharma industry has the most exacting framework around incentive travel of any sector. PhRMA Code, EFPIA Code, MHRA guidelines, IFPMA global rules — each shapes what's permissible, what must be disclosed, and what fair-market-value structures look like. A program designed without compliance at the centre is a program that gets cancelled at T-30 days when legal reviews it.
We build programs the inverse way: compliance frame first, experience second. Counter-intuitively, this produces better experiences. The constraints force us to design programs with substantive working content (which physicians actually appreciate) and avoid the showier patterns that don't survive scrutiny anyway.
Program patterns
Sales rep incentive: 4-5 days, sales kickoff and recognition combined. Cohort 14-22 reps. Heavy product training component. €18,000-€28,000 per person.
KOL working meeting: 3-4 days, KOL faculty + medical affairs + commercial leads. Substantive scientific agenda; experiential program designed around it. €22,000-€34,000 per person.
Medical device partner program: 4-5 days, OEM + key surgeon/customer accounts. Compliance frame per jurisdiction. €22,000-€32,000 per person.
What we will not do
We do not run programs that don't survive compliance review. We do not include spouses in working physician programs without explicit compliance approval. We do not use marketing-style language that would create regulatory exposure. The integrity of your program is more important than our revenue from running it.
Before you enquire
Frequently asked.
- How do you handle pharma compliance frameworks?
- We work within PhRMA Code, EFPIA Code (EU), MHRA guidelines (UK) and IFPMA international frameworks. Programs are structured to satisfy fair market value tests, business purpose requirements, and transparency reporting (Sunshine Act, EFPIA Disclosure Code). We work directly with your compliance and medical affairs teams from program design through documentation.
- Can the program qualify as a bona fide working meeting?
- Yes, when designed correctly. We build programs with substantive scientific or clinical content — typically half-day formal sessions with KOL faculty — alongside the experiential component. The structure satisfies most jurisdictions' working-meeting requirements; your compliance team makes the final determination.
- Are spouses permitted?
- Pharma program rules vary by jurisdiction and product type. In many EU jurisdictions spouses are not permitted on programs with HCP attendees. We confirm rules per program; we never include spouses in working physician programs without explicit compliance sign-off.
- Do you work with medical device and biotech as well?
- Yes — medical device sales incentive, biotech KOL meetings, and CRO partner programs are part of our pharma practice. The compliance envelope differs by product class; we adapt program design accordingly.
Next step
Compliance team welcome on first call.
Send program type, jurisdiction, headcount range, target window. We come back within 48 hours, compliance contacts included on our side.